Literature DB >> 31289146

Minor hallucinations in Parkinson disease: A subtle symptom with major clinical implications.

Abhishek Lenka1, Javier Pagonabarraga2, Pramod Kumar Pal1, Helena Bejr-Kasem1, Jaime Kulisvesky1.   

Abstract

OBJECTIVE: Psychosis is one of the most debilitating complications of Parkinson disease (PD). Although research on PD psychosis has been focused on the study of well-structured visual hallucinations (VH), currently accepted National Institute of Neurological Disorders and Stroke-National Institute of Mental Health diagnostic criteria emphasize minor hallucinations (MH) as the most common psychotic phenomena in PD. The objective of this review is to comprehensively describe the clinical and research advances on the understanding of MH and to provide future directions for obtaining further insights into their potential major implications for PD management and prognosis.
METHODS: A PubMed search was done in November 2018 to identify articles on minor psychotic phenomena in PD.
RESULTS: MH often precede the onset of well-structured VH and are associated with other nonmotor symptoms such as REM sleep behavior disorder and depression. The pattern of functional brain connectivity changes associated with MH involve visual-processing areas and attention control networks, which overlap with abnormalities described in patients with well-structured VH. The dysfunction of cortical networks in patients with MH may be an early indicator of a more widespread form of the disease.
CONCLUSION: Although called "minor," MH may have major clinical and prognostic implications. Further research is needed to establish whether MH are associated with a higher risk of disabling psychotic complications, cognitive deterioration, or a more accelerated disease progression. Understanding the early neurobiological underpinnings of MH may provide the background for future studies to identify the progressive dysfunction of neural circuits leading to more severe forms of psychosis in PD.
© 2019 American Academy of Neurology.

Entities:  

Mesh:

Year:  2019        PMID: 31289146      PMCID: PMC6709995          DOI: 10.1212/WNL.0000000000007913

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  65 in total

Review 1.  Molecular Imaging of the Cholinergic System in Parkinson's Disease.

Authors:  Nicolaas I Bohnen; Prabesh Kanel; Martijn L T M Müller
Journal:  Int Rev Neurobiol       Date:  2018-09-20       Impact factor: 3.230

Review 2.  Structural and functional neuroimaging in patients with Parkinson's disease and visual hallucinations: A critical review.

Authors:  Abhishek Lenka; Ketan Ramakant Jhunjhunwala; Jitender Saini; Pramod Kumar Pal
Journal:  Parkinsonism Relat Disord       Date:  2015-04-17       Impact factor: 4.891

Review 3.  Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients.

Authors:  I Bodis-Wollner
Journal:  Trends Neurosci       Date:  1990-07       Impact factor: 13.837

4.  Neuropsychological correlates of mild to severe hallucinations in Parkinson's disease.

Authors:  Gisela Llebaria; Javier Pagonabarraga; Mercè Martínez-Corral; Carmen García-Sánchez; Berta Pascual-Sedano; Alexandre Gironell; Jaime Kulisevsky
Journal:  Mov Disord       Date:  2010-12-15       Impact factor: 10.338

5.  Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study.

Authors:  D Aarsland; J P Larsen; E Tandberg; K Laake
Journal:  J Am Geriatr Soc       Date:  2000-08       Impact factor: 5.562

6.  A 12-year population-based study of psychosis in Parkinson disease.

Authors:  Elin B Forsaa; Jan Petter Larsen; Tore Wentzel-Larsen; Christopher G Goetz; Glenn T Stebbins; Dag Aarsland; Guido Alves
Journal:  Arch Neurol       Date:  2010-08

7.  Psychiatric comorbidities in patients with Parkinson disease and psychosis.

Authors:  L Marsh; J R Williams; M Rocco; S Grill; C Munro; T M Dawson
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

8.  Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4-year study.

Authors:  G Gibson; P G Mottram; D J Burn; J V Hindle; S Landau; M Samuel; C S Hurt; R G Brown; K C M Wilson
Journal:  Int J Geriatr Psychiatry       Date:  2012-08-28       Impact factor: 3.485

Review 9.  Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

Authors:  Anna Chang; Susan H Fox
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

10.  The pedunculopontine nucleus is related to visual hallucinations in Parkinson's disease: preliminary results of a voxel-based morphometry study.

Authors:  J Janzen; D van 't Ent; A W Lemstra; H W Berendse; F Barkhof; E M J Foncke
Journal:  J Neurol       Date:  2011-06-30       Impact factor: 4.849

View more
  17 in total

Review 1.  Neuroscience robotics for controlled induction and real-time assessment of hallucinations.

Authors:  Fosco Bernasconi; Eva Blondiaux; Giulio Rognini; Herberto Dhanis; Laurent Jenni; Jevita Potheegadoo; Masayuki Hara; Olaf Blanke
Journal:  Nat Protoc       Date:  2022-09-12       Impact factor: 17.021

2.  Face pareidolia is associated with right striatal dysfunction in drug-naïve patients with Parkinson's disease.

Authors:  Hidetomo Murakami; Tomotaka Shiraishi; Tadashi Umehara; Shusaku Omoto; Maki Takahashi; Haruhiko Motegi; Takahiro Maku; Takeo Sato; Hiroki Takatsu; Teppei Komatsu; Keiko Bono; Kenichiro Sakai; Hidetaka Mitsumura; Yasuyuki Iguchi
Journal:  Neurol Sci       Date:  2021-04-22       Impact factor: 3.307

3.  Increasing Contrast Improves Object Perception in Parkinson's Disease with Visual Hallucinations.

Authors:  Mirella Díaz-Santos; Zachary A Monge; Robert D Salazar; Grover C Gilmore; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Mov Disord Clin Pract       Date:  2020-11-17

4.  Visual hallucinations in Lewy body disease: pathophysiological insights from phenomenology.

Authors:  Fabrizia D'Antonio; Maddalena Boccia; Antonella Di Vita; Antonio Suppa; Andrea Fabbrini; Marco Canevelli; Francesca Caramia; Marco Fiorelli; Cecilia Guariglia; Stefano Ferracuti; Carlo de Lena; Dag Aarsland; Dominic Ffytche
Journal:  J Neurol       Date:  2022-01-31       Impact factor: 6.682

5.  Abnormalities in the white matter tracts in patients with Parkinson disease and psychosis.

Authors:  Abhishek Lenka; Madhura Ingalhalikar; Apurva Shah; Jitender Saini; Shyam Sundar Arumugham; Shantala Hegde; Lija George; Ravi Yadav; Pramod Kumar Pal
Journal:  Neurology       Date:  2020-04-21       Impact factor: 11.800

6.  Sleep Disturbances and Associated Factors in Drug-Naïve Patients with Parkinson's Disease.

Authors:  Min Zhong; Xu Jiang; Sha Zhu; Ruxin Gu; Yu Bai; Hong He; Yang Pan; Pingyi Xu; Jun Yan; Li Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-03       Impact factor: 2.570

7.  Prevalence and Risk Factors for Minor Hallucinations in Patients with Parkinson's Disease.

Authors:  Min Zhong; Ruxin Gu; Sha Zhu; Yu Bai; Zhuang Wu; Xu Jiang; Bo Shen; Jun Zhu; Yang Pan; Jun Yan; Li Zhang
Journal:  Behav Neurol       Date:  2021-10-04       Impact factor: 3.342

8.  Identifying Parkinson's disease subtypes with motor and non-motor symptoms via model-based multi-partition clustering.

Authors:  Fernando Rodriguez-Sanchez; Carmen Rodriguez-Blazquez; Concha Bielza; Pedro Larrañaga; Daniel Weintraub; Pablo Martinez-Martin; Alexandra Rizos; Anette Schrag; K Ray Chaudhuri
Journal:  Sci Rep       Date:  2021-12-08       Impact factor: 4.379

Review 9.  Biological links between traumatic brain injury and Parkinson's disease.

Authors:  Vedad Delic; Kevin D Beck; Kevin C H Pang; Bruce A Citron
Journal:  Acta Neuropathol Commun       Date:  2020-04-07       Impact factor: 7.801

Review 10.  Lewy Body Dementias: A Coin with Two Sides?

Authors:  Ángela Milán-Tomás; Marta Fernández-Matarrubia; María Cruz Rodríguez-Oroz
Journal:  Behav Sci (Basel)       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.